In a major advancement for the fields of bioengineering and regenerative medicine, a collaborative research team from the University of…
Read More
Gilead Executive Sounds Alarm on Limited Innovation Investment Hindering Access to Advanced Therapies
The Netherlands faces significant challenges in ensuring timely patient access to life-changing advanced therapy medicinal products (ATMPs), a situation exacerbated…
Read More
Navigating the Biotech Frontier: Investors Reveal Keys to Startup Success at Advanced Therapies Conference
The pursuit of groundbreaking innovation in advanced therapeutic medicinal products (ATMPs) is a high-stakes endeavor, particularly for early-stage biotech startups…
Read More
